Ongoing experience of implementing "the toronto protocol": an ultra-short course glecapriver/pibrentasvir with ezetimibe for solid organ transplantation from hcv-infected donors to hcv-uninfected recipients

HEPATOLOGY(2023)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要